BPG is committed to discovery and dissemination of knowledge
Prospective Study
©Author(s) (or their employer(s)) 2026.
World J Crit Care Med. Mar 9, 2026; 15(1): 115599
Published online Mar 9, 2026. doi: 10.5492/wjccm.v15.i1.115599
Table 1 Demographic parameters, mortality scores and duration parameters
Variable
n (%)/mean ± SD
P value1
r
P value2
Age 61.5 ± 14.60.594-0.1860.071
GenderMale/female52/43 (54.73/40.85)0.4640.1000.333
BMI 26.2 ± 5.40.1070.0350.736
Mortality scores
APACHE21.7 ± 7.60.3450.2520.014
SAPS II57.07 ± 15.190.3380.3280.001
SOFA10.93 ± 3.630.700-0.1650.109
Duration indicators
ETI, yes/no84/11 (79.80/10.45)0.4070.1460.159
MV9.21 ± 15.120.0130.2800.006
LOS 13.63 ± 16.050.005-0.0980.342
Table 2 Correlation of laboratory findings with fatal outcome
VariableT0, day 0
T1, day 1
T2, day 3
T3, day 7
P value1
r
P value2
P value1
r
P value2
P value1
r
P value2
P value1
r
P value2
WBC0.399-0.0700.4990.483-0.1160.2640.195-0.0940.3670.0050.2080.044
RBC0.1610.1170.2580.0950.6280.0500.0270.0620.5530.045-0.2490.015
PLT0.2160.1060.3090.1520.1070.3010.4440.1470.1550.409-0.2700.008
NEU0.4580.2440.0170.626-0.0770.4590.1110.3000.0030.1200.3040.003
LYM0.7580.1500.1480.4170.1120.2790.0490.2800.0060.0520.1210.242
pH0.467-0.1090.2950.1230.4010.0000.122-0.4240.0000.063-0.4510.000
pO20.5750.0960.3530.380-0.0360.7390.249-0.3350.0010.027-0.2490.015
pCO20.265-0.1710.0970.365-0.0440.6710.413-0.1790.0820.9160.2320.024
HCO30.0690.1580.1270.090-0.2510.0140.567-0.2350.0020.1500.1130.276
BE0.0130.2570.0120.144-0.2850.0050.6630.2890.0040.4910.1940.060
Lactate0.541-0.1980.0550.7960.2610.0110.0580.2190.0330.217-01950.059
Albumin0.556-0.0270.7980.1130.0070.9430.074-0.2360.0210.051-0.3370.001
CRP0.600-0.0060.9530.932-0.1520.1410.291-0.1500.1460.3640.3720.000
PCT0.372-0.0440.6710.400-0.0220.8310.106-0.1450.1610.493-0.0970.348
TSH0.587-0.0690.5080.2480.1110.1650.0790.0950.3590.026-0.0670.548
FT30.0890.0390.7060.007-0.1020.3260.028-0.2360.0210.198-0.2490.015
FT40.000-0.0840.4200.0000.0060.9510.021-0.3340.0010.011-0.3310.001
Table 3 Correlation of the effects of vasoactive agents and inflammatory prognostic scores with fatal outcome
VariableT0, day 0
T1, day 1
T2, day 3
T3, day 7
P value1
r
P value2
P value1
r
P value2
P value1
r
P value2
P value1
r
P value2
Effects of vasoactive agents
VDI0.389-0.1250.2290.074-0.1220.2290.814-0.1280.2170.842-0.1220.237
SI0.206-0.1550.1340.080-0.1970.1340.027-0.1820.0780.0000.2680.009
Inflammatory prognostic scores
NLR0.7120.2640.0100.6890.2590.0100.2360.2810.0060.1760.3370.001
PLR0.351-0.1600.1200.367-0.1930.1200.2000.2140.0370.659-0.1450.162
mGPS0.4960.0600.5660.030-0.2240.5660.128-0.1060.3060.308-0.1080.298
PI0.3280.2200.0320.3050.2860.0050.1000.2390.0190.3270.2830.006